Citigroup Inc Pacira Bio Sciences, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 90,589 shares of PCRX stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,589

Previous 41,803 116.7%

Holding current value

$1.76 Million

Previous $1.2 Million 14.14%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$11.7 - $28.46 $570,796 - $1.39 Million	48,786 Added 116.7%	90,589 $1.36 Million
Q2 2024 Aug 12, 2024	BUY	$25.5 - $31.51 $96,390 - $119,107	3,780 Added 9.94%	41,803 $1.2 Million
Q1 2024 May 10, 2024	SELL	$27.7 - $35.48 $30,359 - $38,886	-1,096 Reduced 2.8%	38,023 $1.11 Million
Q4 2023 Feb 09, 2024	SELL	$26.32 - $34.31 $369,585 - $481,781	-14,042 Reduced 26.41%	39,119 $1.32 Million
Q3 2023 Nov 09, 2023	BUY	$30.68 - $40.09 $296,614 - $387,590	9,668 Added 22.23%	53,161 $1.63 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $47.5 $552,672 - $726,797	15,301 Added 54.27%	43,493 $1.74 Million
Q1 2023 May 11, 2023	SELL	$35.53 - $43.38 $158,783 - $193,865	-4,469 Reduced 13.68%	28,192 $1.15 Million
Q4 2022 Feb 09, 2023	BUY	$38.19 - $57.45 $135,230 - $203,430	3,541 Added 12.16%	32,661 $1.26 Million
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $32,742 - $37,630	639 Added 2.24%	29,120 $1.55 Million
Q2 2022 Aug 10, 2022	SELL	$51.49 - $81.64 $1.09 Million - $1.72 Million	-21,121 Reduced 42.58%	28,481 $1.66 Million
Q1 2022 May 12, 2022	BUY	$60.03 - $76.49 $292,826 - $373,118	4,878 Added 10.91%	49,602 $3.79 Million
Q4 2021 Feb 10, 2022	SELL	$47.97 - $62.21 $733,749 - $951,564	-15,296 Reduced 25.48%	44,724 $2.69 Million
Q3 2021 Nov 10, 2021	BUY	$54.64 - $61.3 $3.28 Million - $3.68 Million	60,020 New	60,020 $3.36 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account